Table 1. Demographic characteristics of the patients receiving cisplatin with and without exposure to hyperoxia.
Table 2. Incidence of cisplatin-induced nephrotoxicity in two groups.
Table 3. Renal function comparisons in pre- and post-treatment between both groups.
Figure 1. GFR trend.
Table 4. GFR changes trend; within and between subjects variations.
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
